
| Phytochemical Name | Isorhamnetin |
| PubChem CID | 5281654 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Chloroquine; Doxorubicin |
| Source |
Warm
Inula japonica;
Hippophae rhamnoides
Even
Ginkgo bilobe;
|
| Phytochemical Name | Isorhamnetin |
| PubChem CID | 5281654 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Chloroquine; Doxorubicin |
| Source |
Warm
Inula japonica;
Hippophae rhamnoides
Even
Ginkgo bilobe;
|
| Phytochemical Name | Isorhamnetin |
| PubChem CID | 5281654 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Chloroquine; Doxorubicin |
| Source |
Warm
Inula japonica;
Hippophae rhamnoides
Even
Ginkgo bilobe;
|
| Phytochemical Name | Isorhamnetin |
| PubChem CID | 5281654 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Chloroquine; Doxorubicin |
| Source |
Warm
Inula japonica;
Hippophae rhamnoides
Even
Ginkgo bilobe;
|
| Phytochemical Name | Isorhamnetin |
| PubChem CID | 5281654 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Chloroquine; Doxorubicin |
| Source |
Warm
Inula japonica;
Hippophae rhamnoides
Even
Ginkgo bilobe;
|
| Phytochemical Name | Isorhamnetin |
| PubChem CID | 5281654 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Chloroquine; Doxorubicin |
| Source |
Warm
Inula japonica;
Hippophae rhamnoides
Even
Ginkgo bilobe;
|